Joseph D. Janizek

Joseph D. Janizek

Auto-generated profile, based on publicly available information

Joseph D. Janizek

Paul G. Allen School of Computer Science and Engineering, University of Washington, Seattle, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2018 in Nature
Verified
Journal Article
Closed access
PDF file
GFGregory M. Findlay
Gregory M. Findlay
RDRiza M. Daza
Riza M. Daza
BMBeth Martin
Beth Martin
MZMelissa D. Zhang
Melissa D. Zhang
ALAnh P. Leith
Anh P. Leith
JSJay Shendure
Jay Shendure

31 May 2021 in Nature Machine Intelligence
Verified
Journal Article
Closed access
PDF file
ADAlex J. DeGrave
Alex J. DeGrave
JJJoseph D. Janizek
Joseph D. Janizek
SLSu-In Lee
Su-In Lee

14 September 2020 in medRxiv
Verified
Preprint
Open access
PDF file
ADAlex J. DeGrave
Alex J. DeGrave
JJJoseph D. Janizek
Joseph D. Janizek
SLSu-In Lee
Su-In Lee
Artificial intelligence (AI) researchers and radiologists have recently reported AI systems that accurately detect COVID-19 in chest radiographs. However, the robustness of these systems remains unclear. Using state-of-the-art techniques in explainable AI, we demonstrate that recent deep learning systems to detect COVID-19 from chest radiographs rely on confounding factors rather than medical pathology, creating an alarming situation in which the systems appear accurate, but fail when tested in new hospitals.

2 April 2020
Verified
Conference Paper
Open access
JJJoseph D. Janizek
Joseph D. Janizek
GEGabriel Erion
Gabriel Erion
ADAlex J. DeGrave
Alex J. DeGrave
SLSu-In Lee
Su-In Lee
While deep learning has shown promise in the domain of disease classification from medical images, models based on state-of-the-art convolutional neural network architectures often exhibit performance loss due to dataset shift. Models trained using data from one hospital system achieve high predictive performance when tested on data from the same hospital, but perform significantly worse when they are tested in different hospital systems. Furthermore, even within a given hospital system, deep learning models have been shown to depend on hospital- and patient-level confounders rather than meaningful pathology to make classifications. In order for these models to be safely deployed, we would like to ensure that they do not use confounding variables to make their classification, and that they will work well even when tested on images from hospitals that were not included in the training data. We attempt to address this problem in the context of pneumonia classification from chest radiographs. We propose an approach based on adversarial optimization, which allows us to learn more robust models that do not depend on confounders. Specifically, we demonstrate improved out-of-hospital generalization performance of a pneumonia classifier by training a model that is invariant to the view position of chest radiographs (anterior-posterior vs. posterior-anterior). Our approach leads to better predictive performance on external hospital data than both a standard baseline and previously proposed methods to handle confounding, and also suggests a method for identifying models that may rely on confounders.

17 December 2024 in Nature Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
WQWei Qiu
Wei Qiu
ADAyse B. Dincer
Ayse B. Dincer
JJJoseph D. Janizek
Joseph D. Janizek
SCSafiye Celik
Safiye Celik
MPMikael J. Pittet
Mikael J. Pittet
SLSu-In Lee
Su-In Lee

5 April 2018 in bioRxiv
Verified
Preprint
Open access
PDF file
GFGregory M. Findlay
Gregory M. Findlay
RDRiza M. Daza
Riza M. Daza
BMBeth Martin
Beth Martin
MZMelissa D. Zhang
Melissa D. Zhang
ALAnh P. Leith
Anh P. Leith
JSJay Shendure
Jay Shendure
Variants of uncertain significance (VUS) fundamentally limit the utility of genetic information in a clinical setting. The challenge of VUS is epitomized by BRCA1 , a tumor suppressor gene integral to DNA repair and genomic stability. Germline BRCA1 loss-of-function (LOF) variants predispose women to early-onset breast and ovarian cancers. Although BRCA1 has been sequenced in millions of women, the risk associated with most newly observed variants cannot be definitively assigned. Data sharing attenuates this problem but it is unlikely to solve it, as most newly observed variants are exceedingly rare. In lieu of genetic evidence, experimental approaches can be used to functionally characterize VUS. However, to date, functional studies of BRCA1 VUS have been conducted in a post hoc , piecemeal fashion. Here we employ saturation genome editing to assay 96.5% of all possible single nucleotide variants (SNVs) in 13 exons that encode functionally critical domains of BRCA1. Our assay measures cellular fitness in a haploid human cell line whose survival is dependent on intact BRCA1 function. The resulting function scores for nearly 4,000 SNVs are bimodally distributed and almost perfectly concordant with established assessments of pathogenicity. Sequence-function maps enhanced by parallel measurements of variant effects on mRNA levels reveal mechanisms by which loss-of-function SNVs arise. Hundreds of missense SNVs critical for protein function are identified, as well as dozens of exonic and intronic SNVs that compromise BRCA1 function by disrupting splicing or transcript stability. We predict that these function scores will be directly useful for the clinical interpretation of cancer risk based on BRCA1 sequencing. Furthermore, we propose that this paradigm can be extended to overcome the challenge of VUS in other genes in which genetic variation is clinically actionable.